Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1422142/000119312521257910/d119681d8k.htm
SEC Filings
ARPO Annual Reports
10-K Annual Report March 2021
10-K Annual Report March 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report February 2015
10-K Annual Report March 2014
10-K Annual Report March 2013
10-K Annual Report March 2012
10-K Annual Report March 2021
10-K Annual Report March 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report February 2015
10-K Annual Report March 2014
10-K Annual Report March 2013
10-K Annual Report March 2012
ARPO Quarterly Reports
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report November 2018
10-Q Quarterly Report August 2018
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report November 2018
10-Q Quarterly Report August 2018
ARPO Corporate News
Financial Exhibit
New Agreement August 2021
Vote of Security Holders August 2021
Earnings Release
Financial Exhibit August 2021
Financial Exhibit
Regulated Disclosure
Vote of Security Holders July 2021
Financial Exhibit
Regulated Disclosure June 2021
Earnings Release
Financial Exhibit May 2021
Bylaw Change
Change in Control
Event for Officers
Financial Exhibit
New Agreement
Regulated Disclosure
Unregistered Sales May 2021
Event for Officers
Financial Exhibit April 2021
Financial Exhibit
New Agreement
New Agreement
August 2021
Vote of Security Holders
August 2021
Earnings Release
Financial Exhibit
Financial Exhibit
August 2021
Financial Exhibit
Regulated Disclosure
Vote of Security Holders
Regulated Disclosure
Vote of Security Holders
July 2021
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
June 2021
Earnings Release
Financial Exhibit
Financial Exhibit
May 2021
Bylaw Change
Change in Control
Event for Officers
Financial Exhibit
New Agreement
Regulated Disclosure
Unregistered Sales
Change in Control
Event for Officers
Financial Exhibit
New Agreement
Regulated Disclosure
Unregistered Sales
May 2021
Event for Officers
Financial Exhibit
Financial Exhibit
April 2021
Last10K.com | 8-K Material Event Fri Aug 27 2021
View differences made from one to another to evaluate Aerpio Pharmaceuticals, Inc.'s financial trajectory
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aerpio Pharmaceuticals, Inc..
Assess how Aerpio Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy
Aerpio Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Aerpio Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Exhibit 3.1: Articles Of Incorporation
Exhibit 3.2: Articles Of Incorporation
Exhibit 10.1: Material Contract
Exhibit 10.3: Material Contract
Exhibit 10.4: Material Contract
Exhibit 10.5: Material Contract
Exhibit 10.6: Material Contract
Exhibit 10.7: Material Contract
Exhibit 10.8: Material Contract
Exhibit 10.9: Material Contract
Exhibit 10.10: Material Contract
Exhibit 10.11: Material Contract
Exhibit 14.1: Code Of Ethics
Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Ticker: ARPOEvents:
CIK: 1422142
Form Type: 8-K Corporate News
Accession Number: 0001193125-21-257910
Submitted to the SEC: Thu Aug 26 2021 9:36:06 PM EST
Accepted by the SEC: Fri Aug 27 2021
Period: Thursday, August 26, 2021
Industry: Pharmaceutical Preparations
- Bylaw Change
- Change in Assets
- Change in Control
- Code of Ethics Change
- Event for Officers
- Financial Exhibit
- New Agreement
- Security Holders Change
- Unregistered Sales
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/arpo/0001193125-21-257910.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...